BioSpace News Archive

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has been included in the Defiance Next Gen Altered Experience ETF,

Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today the publication of a new peer-reviewed paper on its eQUANT™ system and technology in Scientific Reports.

SOPHiA GENETICS, the creator of a global data-sharing network that advances data-driven medicine, today released SOPHiA DDM™ for Blood Cancers, novel blood cancer testing solutions across the entire workflow from setup, genomic testing, and in-house advanced analytics.

Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company”, “Hollister Cannabis Co.” or “Hollister”) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 95 dispensaries throughout Arizona, today reported its financial and operating results for the first quarter of 2021

Annual Program Builds on WCG IRB’s Expertise and 50-Year Legacy of Global Service, Protecting Safety of Clinical Trial Participants, Preserving Scientific Integrity of Research Protocols

GTCR, a leading private equity firm, announced today that Resonetics has completed an acquisition of Distal Solutions.

National Kidney Foundation launches Voices for Kidney Health™, a diverse nationwide community of dedicated kidney patient and health professional advocates working with elected officials and other public leaders to create policies and initiatives that help those living with kidney disease and to promote better kidney health.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today plans to host a virtual information session on its pipeline product, HT-KIT , a new molecular entity under development for treatment of mast cell-derived cancers and anaphylaxis, on Thursday, June 3rd for interested shareholders.

Silverback Therapeutics to Participate in the Goldman Sachs 42 nd Annual Global Healthcare Conference

Rubedo Life Sciences , a drug discovery company developing targeted therapeutics for age-related diseases, today announced a collaboration with Cedars-Sinai Medical Center in Los Angeles, to advance its idiopathic pulmonary fibrosis (IPF) program and establish collaborative studies.